e-learning
resources
Stockholm 2007
Monday 17.09.2007
COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Maximal airway response in patients with asthma and cough variant asthma
Y. Havlucu (Hatay, Turkey)
Source:
Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Session:
COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Session type:
Thematic Poster Session
Number:
2238
Disease area:
Airway diseases, Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Havlucu (Hatay, Turkey). Maximal airway response in patients with asthma and cough variant asthma. Eur Respir J 2007; 30: Suppl. 51, 2238
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Airway responsiveness in patients with cough variant asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 50s
Year: 2002
Longitudinal decline of pulmonary function in cough variant asthma and atopic cough
Source: Eur Respir J 2002; 20: Suppl. 38, 50s
Year: 2002
Effects of corticosteroids on airway inflammation in cough variant asthma
Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring
Year: 2004
Spontaneous airway obstruction masks FeNO level in patients with asthma but not COPD
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Relationship between bronchial hyperresponsiveness and response to β
2
-agonists in steroid-naïve patients with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 503s
Year: 2002
Cough variant asthma may be a incipience of bronchial asthma
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Differences and similarities between patients with cough variant asthma and cough predominant asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Bronchial challenge test in patients with chronic persistent cough and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 475s
Year: 2003
Bronchial hyperreactivity in children with cough variant of bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 473s
Year: 2002
Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
Source: Annual Congress 2009 - Accuracy in lung function testing
Year: 2009
Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma
Year: 2006
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009
Variants of allergic response in children with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004
Effect of aerobic training on airway inflammation and asthma symptoms in asthmatic patients
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009
Predictors for asthma onset from cough variant asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 409s
Year: 2002
Same role and same treatment for airway eosinophilia in asthma and COPD?
Source: Eur Respir J 2007; 29: 831-833
Year: 2007
Cough during airway challenges: associations with bronchoconstriction and asthma
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept